Profil
Michael Wheatcroft currently works at Telix Pharmaceuticals Ltd., as Chief Scientist from 2021.
Dr. Wheatcroft also formerly worked at MedImmune U.K.
Ltd., as Principal and Avipep Pty Ltd., as Research Manager.
Dr. Wheatcroft received his doctorate degree from the University of Cambridge.
Postes actifs de Michael Wheatcroft
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Michael Wheatcroft
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune U.K. Ltd.
MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Corporate Officer/Principal | - |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Corporate Officer/Principal | - |
Formation de Michael Wheatcroft
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedImmune U.K. Ltd.
MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Health Technology |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
















